x
Filter:
Filters applied
- Free Access
- ethicsRemove ethics filter
Keyword
- abortion1
- assisted human reproduction1
- assisted reproductive techniques1
- baby factory1
- confusion1
- dehydroepiandrosterone1
- diminished ovarian reserve1
- dissimilarities1
- egg donation1
- enhancement1
- eugenics1
- fetal reduction of multiple pregnancy1
- genetics1
- genome-editing technology1
- grief1
- in-vitro fertilization1
- infertility1
- international harmonization1
- IVF1
- mitochondrial disease1
- mitochondrial replacement technology1
- multiple pregnancy1
- poor response1
- procreative beneficence1
Free Access Articles
6 Results
- Commentary
Baby factories taint surrogacy in Nigeria
Reproductive BioMedicine OnlineVol. 32Issue 1p6–8Published online: October 14, 2015- Olusesan Ayodeji Makinde
- Olufunmbi Olukemi Makinde
- Olalekan Olaleye
- Brandon Brown
- Clifford O. Odimegwu
Cited in Scopus: 11The practice of reproductive medicine in Nigeria is facing new challenges with the proliferation of ‘baby factories’. Baby factories are buildings, hospitals or orphanages that have been converted into places for young girls and women to give birth to children for sale on the black market, often to infertile couples, or into trafficking rings. This practice illegally provides outcomes (children) similar to surrogacy. While surrogacy has not been well accepted in this environment, the proliferation of baby factories further threatens its acceptance. - Commentary
Potential impact of human mitochondrial replacement on global policy regarding germline gene modification
Reproductive BioMedicine OnlineVol. 29Issue 2p150–155Published online: April 23, 2014- Tetsuya Ishii
Cited in Scopus: 49Previous discussions regarding human germline gene modification led to a global consensus that no germline should undergo genetic modification. However, the UK Human Fertilisation and Embryology Authority, having conducted at the UK Government’s request a scientific review and a wide public consultation, provided advice to the Government on the pros and cons of Parliament’s lifting a ban on altering mitochondrial DNA content of human oocytes and embryos, so as to permit the prevention of maternal transmission of mitochondrial diseases. - Commentary
The ethics of creating children with three genetic parents
Reproductive BioMedicine OnlineVol. 26Issue 6p531–534Published online: March 27, 2013- Françoise Baylis
Cited in Scopus: 96This article on mitochondrial replacement technology briefly explains and defends the legitimacy of such terms as ‘three-parent embryos’, ‘three-parent babies’ and ‘three-person IVF’. Next, it reviews select ethical objections to mitochondrial replacement technology that fall into four, sometimes overlapping, categories: (i) harms to egg providers; (ii) harms to potential offspring and future generations; (iii) harms to specific interest groups; and (iv) harms to society. Taken together, these ethical objections are cause for serious concern and yet the development and future use of mitochondrial replacement technology is likely inevitable. - CommentaryOpen Access
Selective termination, fetal reduction and analogical reasoning
Reproductive BioMedicine OnlineVol. 26Issue 6p525–527Published online: March 15, 2013- G. Pennings
Cited in Scopus: 0Analogical reasoning is a basic method in bioethics. Its main purpose is to transfer the rule from an existing or known situation to a new and problematic situation. This commentary applies the lifeboat analogy to the context of selective termination and fetal reduction. It turns out that the analogy is only partially helpful as the main principle in the case of selective termination is the procreative beneficence principle. However, the wide person-affecting form of this principle doubly justifies selective termination: i.e. - Review
Differences between selective termination of pregnancy and fetal reduction in multiple pregnancy: a narrative review
Reproductive BioMedicine OnlineVol. 26Issue 6p542–554Published online: February 18, 2013- Claire-Marie Legendre
- Grégoire Moutel
- Régen Drouin
- Romain Favre
- Chantal Bouffard
Cited in Scopus: 8Although selective termination of pregnancy and fetal reduction in multiple pregnancy both involve the termination in utero of the development of live fetuses, these two procedures are different in several aspects. Nevertheless, several authors tend to amalgamate and confuse their psychosocial consequences and the ethical issues they raise. Therefore, this narrative review, derived from a comparative analysis of 91 articles, shines a light on these amalgamations and confusions, as well as on the medical, contextual, experiential and ethical differences specific to selective termination and fetal reduction. - Commentary
Hype or hope? Ethical and practical considerations with clinical research in women with diminished ovarian reserve
Reproductive BioMedicine OnlineVol. 25Issue 2p98–102Published online: April 23, 2012- Norbert Gleicher
- David H. Barad
Cited in Scopus: 3This communication suggests that investigations of treatments for women with diminished functional ovarian reserve (DOR) call for specific practical and ethical considerations, as women with DOR, because of limited remaining reproductive life spans, appropriately feel under time constraints. Another medical journal recently published an opinion piece on the use of dehydroepiandrosterone in women with DOR, raising important questions about what approaches should be taken to develop best available evidence in such patients.
